Las Vegas, NV -- (SBWIRE) -- 10/10/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Generex Biotechnology Corporation (OTCMKTS: GNBT), Dynavax Technologies Corporation (NASDAQ:DVAX), Delcath Systems, Inc. (NASDAQ:DCTH), Ceres Inc (NASDAQ:CERE)
Generex Biotechnology Corporation (OTCMKTS: GNBT) managed to keep its fall at -3.27% on above-normal volume of 3.17M shares. The stock settled at $0.0296 after floating in a range of $0.03 to $0.03. Its latest price has reached market capitalization of $14.83 million. Its 52-week range has been $0.02 to $0.07. Generex Biotechnology Corporation is a Canada-based Company, which develops drug delivery systems and technologies for the treatment of diabetes.
Has GNBT Found The Bottom and Ready To Move Up? Find Out Here
Dynavax Technologies Corporation (NASDAQ:DVAX) traded down on a volume of 3.14 million, higher than its standard daily volume. Shares have dropped-6.61% to $1.13. Over the last twelve months, the stock has lost-76.75% and faced a worst price of $0.98. Dynavax Technologies Corporation (Dynavax) is a clinical-stage biopharmaceutical company, discovers and develops products to prevent and treat infectious and inflammatory diseases.
Has DVAX Found The Bottom And Ready To Gain Momentum? Find Out Here
Delcath Systems, Inc. (NASDAQ:DCTH) settled -8.41% lower at $0.403 on below -normal volume of 3.09M shares during the last trading day. The stock has its 12-month high at $2.38 and 52-week low price was $0.29. It traded in a range of $0.40 to $0.46 during the last trading day. Delcath Systems, Inc. operates as a specialty pharmaceutical and medical device company focusing on the field of oncology.
Will DCTH Get Buyers Even After The Recent Rally? Find Out Here
In the last trading session, Ceres Inc (NASDAQ:CERE) was up on high volume, trading at a volume of 2.94M versus its average daily volume of 753,766.00 shares. At $1.82, the stock has attained market capitalization of 45.33 million. Ceres, Inc. (Ceres) is an agricultural biotechnology company selling seeds to produce renewable biomass feedstocks.
Will CERE Continue To Move Higher? Find Out Here
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimer at: http://www.equityobserver.com/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)